OpenNeedle Ask your own

Question explored with the scientific record

What is bio identical hrt made from?

Sep 10, 2026 · 4 sources used · OpenNeedle synthesis
The short version: bioidentical HRT is made from hormones that are chemically identical to what your body makes, but "bioidentical" is a marketing term, not a safety guarantee.

Bioidentical hormone replacement therapy is made from estradiol, progesterone, and sometimes testosterone that are molecularly identical to the hormones your own body produces. The most common form is 17β-estradiol combined with natural progesterone, often in a single capsule [1]. The plant sources matter less than the final molecule: yams and soy provide raw material that gets converted in a lab into the exact human hormone structure. That is the whole meaning of "bioidentical" — the molecule matches yours, unlike synthetic progestins such as medroxyprogesterone, which do not.

The evidence here is thin on what you actually need to know. One study describes a phase 3 trial of estradiol plus natural progesterone for hot flashes, but it was designed to measure symptom relief and endometrial safety over 12 months, not long-term outcomes like heart disease, cancer, or blood clots [1]. A case report from 2021 shows a real harm: a post-menopausal woman on bioidentical HRT developed significant virilization, meaning male-pattern changes, from the testosterone component [4]. That tells you these are potent hormones with real effects, and the retrieval contains no long-term safety data comparing bioidentical HRT against placebo or against synthetic hormones for hard outcomes like death or cancer.

The burden of proof sits on the intervention, and the retrieved studies do not meet it. A 12-month symptom trial is not evidence of safety over a decade of use. The formulation science in the records — drug crystallization in patches, implant delivery systems — is about manufacturing, not about your body [2, 3]. What is missing is the layer that matters most: what happens to the person taking these hormones for years, and how the colloidal stability of blood and the immune system respond to chronic exogenous hormone exposure. That question is not answered here.

My call: bioidentical HRT is chemically what it claims to be, but the evidence retrieved does not establish long-term safety, and the virilization case shows real harm is possible. Confidence: low — the retrieval is too thin to make a firm safety call either way.

Keep digging

Sources used 4

  1. 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review Maturitas (2015) Thin

    A phase 3, randomized, double-blind, placebo-controlled study design and evidence review of TX-001HR, a single-capsule combination of 17β-estradiol and natural progesterone for treating menopausal vasomotor symptoms, plus a synthesis of literature on hormone therapy differences …

    DOI: 10.1016/j.maturitas.2015.02.266
  2. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS International Journal of Pharmaceutics (2020) Thin

    This study quantitatively links drug recrystallization in testosterone-loaded drug-in-adhesive transdermal patches to progressive deterioration of adhesion, rheological behavior, and both in vitro drug release and skin permeation as crystalline content increases beyond ~2% w/w.

    DOI: 10.1016/j.ijpharm.2020.119132
  3. Sustained suppression of pituitary‐gonadal axis with an injectable, in situ forming implant of leuprolide acetate Journal of Pharmaceutical Sciences (2000) Thin

    The study develops and tests an injectable, in situ forming Atrigel implant delivering leuprolide acetate in rats to achieve sustained suppression of the pituitary-gonadal axis (serum testosterone) for at least 3 months, identifying a lead formulation (75/25 PLG in NMP at 3% dru…

    DOI: 10.1002/(SICI)1520-6017(200006)89:6<732::AID-JPS4>3.0.CO;2-D
  4. Bioidentical Hormone Replacement Therapy at a Hormone Clinic Causing Significant Virilization in a Post-Menopausal Women Journal of the Endocrine Society (2021) Thin

    This case report describes an 18-year-old Vietnamese female with primary amenorrhea due to Müllerian agenesis, highlighting imaging findings of absent uterus and accompanying hormonal evaluation.

    DOI: 10.1210/jendso/bvab048.1583

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question